Wright pads out extremities
This article was originally published in Clinica
Executive Summary
Wright Medical has inked a deal to buy Biotech International, a French orthopedic extremities company, in a bid to grow its direct sales channel outside the US. Arlington, Tennessee-headquartered Wright sold its reconstructive implant business as part of its strategy to focus exclusively on extremities earlier this year (www.clinica.co.uk, 20 June 2013). Wright will pay $75m upfront for Biotech using a mix of $55m cash and $20m stock; it has also agreed to pay a further $5m in revenue milestones in 2013 and 2015.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.